VF
EDIT icon

Virtu Financial’s Editas Medicine EDIT Stock Holding History

Virtu Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,228
Closed -$89K – 1798
2025
Q4 		$89K Buy
+43,228
New +$125K ﹤0.01% 1225
2025
Q3 		– Sell
-126,972
Closed -$279K – 1615
2025
Q2 		$279K Buy
+126,972
New +$208K 0.01% 783
2025
Q1 		– Sell
-70,980
Closed -$90K – 1524
2024
Q4 		$90K Buy
+70,980
New +$181K ﹤0.01% 1043
2024
Q2 		– Sell
-40,461
Closed -$300K – 1444
2024
Q1 		$300K Sell
40,461
-33,425
-45% -$278K 0.02% 615
2023
Q4 		$748K Buy
+73,886
New +$649K 0.06% 272
2023
Q3 		– Sell
-33,355
Closed -$275K – 1451
2023
Q2 		$275K Buy
+33,355
New +$291K 0.02% 644
2022
Q4 		– Sell
-31,055
Closed -$380K – 1746
2022
Q3 		$380K Sell
31,055
-757
-2% -$11.8K 0.03% 533
2022
Q2 		$376K Buy
+31,812
New +$426K 0.03% 480
2021
Q4 		– Sell
-51,160
Closed -$2.1M – 1831
2021
Q3 		$2.1M Buy
+51,160
New +$2.8M 0.19% 88
2021
Q2 		– Sell
-19,203
Closed -$807K – 1644
2021
Q1 		$807K Buy
19,203
+244
+1% +$13.9K 0.06% 316
2020
Q4 		$1.33M Buy
18,959
+1,012
+6% +$41.6K 0.14% 176
2020
Q3 		$504K Sell
17,947
-17,556
-49% -$572K 0.09% 285
2020
Q2 		$1.05M Buy
+35,503
New +$928K 0.12% 186
2019
Q4 		$535K Buy
+18,068
New +$451K 0.05% 388
2019
Q1 		– Sell
-8,896
Closed -$202K – 1503
2018
Q4 		$202K Sell
8,896
-586
-6% -$15.9K 0.01% 958
2018
Q3 		$302K Sell
9,482
-2,663
-22% -$86.1K 0.02% 844
2018
Q2 		$435K Sell
12,145
-5,219
-30% -$185K 0.03% 882
2018
Q1 		$576K Buy
+17,364
New +$619K 0.03% 631

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Virtu Financial's EDIT Position: Q1 2026 in Review

Virtu Financial sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 43,228 shares — an estimated $89K sold.

Virtu Financial first reported a position in EDIT in Q1 2018 and held it in 18 quarters. The position peaked at $2.1M in Q3 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Virtu Financial reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 43,228 Editas Medicine shares in Q1 2026, an estimated $89K.
  • Virtu Financial first reported a position in Editas Medicine in Q1 2018 and held it in 18 quarters.
  • Virtu Financial's Editas Medicine position peaked at $2.1M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.